Key points are not available for this paper at this time.
None of the six points chosen for emphasis was known with certainty as little as 10 years ago. Although other points for emphasis may be chosen, those emphasized in this review could have a major impact on how we judge success in future clinical trials.
David Osoba (1994) studied this question.